Lakefront Biotherapeutics (LKFT) Change in Inventory (2015 - 2020)
Lakefront Biotherapeutics (LKFT) posted quarterly Change in Inventory of $120059.2 for Q2 2020, up 2236.97% year-over-year from $5137.4 in Q3 2019, and up 275.41% quarter-over-quarter from -$68444.2 in Q1 2020.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Change in Inventory (2015 - 2020) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Change in Inventory for 5 consecutive years, with $120059.2 the latest figure, recorded in Q2 2020.
- In Q2 2020, Change in Inventory rose 2236.97% year-over-year to $120059.2; the TTM figure through Jun 2020 stood at $32832.9 (up 358.13% YoY), while the FY2025 annual figure was $33.6 million, up 36.41% from the prior year.
- Change in Inventory grew to $120059.2 in Q2 2020 per LKFT's latest filing, from -$68444.2 in the prior quarter.
- Across five years, Change in Inventory topped out at $21.1 million in Q3 2017 and bottomed at -$19.8 million in Q2 2017.
- Historically, Change in Inventory has averaged $84842.6 across 5 years, with a median of -$3950.5 in 2018.
- Annual changes were most pronounced in 2017 — Change in Inventory sank 67382.79% — and 2020, when it jumped 2236.97%.
- Lakefront Biotherapeutics' Change in Inventory stood at $29376.8 in 2016, then plunged by 196.19% to -$28258.4 in 2017, then surged by 91.92% to -$2282.8 in 2018, then sank by 1015.23% to -$25458.4 in 2019, then jumped by 571.59% to $120059.2 in 2020.
- Business Quant data shows LKFT's Change in Inventory at $120059.2 in Q2 2020, -$68444.2 in Q1 2020, and -$25458.4 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 120,059.15 |
| Mar 31, 2020 | -68,444.22 |
| Dec 31, 2019 | -25,458.42 |
| Sep 30, 2019 | 6,676.38 |
| Jun 30, 2019 | -5,618.20 |
| Mar 31, 2019 | 2,273.26 |
| Dec 31, 2018 | -2,282.79 |
| Sep 30, 2018 | 12,794.42 |
| Jun 30, 2018 | 2,386.89 |
| Mar 31, 2018 | -17,199.46 |
| Dec 31, 2017 | -28,258.38 |
| Sep 30, 2017 | 21.15 Mn |
| Jun 30, 2017 | -19.77 Mn |
| Mar 31, 2017 | -25,569.77 |
| Jun 30, 2016 | 29,376.75 |
| Mar 31, 2016 | -25,369.28 |
| Dec 31, 2015 | -48,229.16 |